These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. [Aplastic syndrome in myleran overdose]. Albrecht M; Tackmann W; Pribilla W Med Klin; 1971 Jan; 66(4):126-30. PubMed ID: 5278287 [No Abstract] [Full Text] [Related]
49. [Treatment of chronic myeloid leukemia with dibromomannitol]. Clément F; Saillen R Schweiz Med Wochenschr; 1970 Nov; 100(46):1995-7. PubMed ID: 5279364 [No Abstract] [Full Text] [Related]
50. Cholestatic jaundice following treatment of chronic granulocytic leukemia with busulphan. Underwood JC; Shahani RT; Blackburn EK J Clin Pathol; 1970 Dec; 23(9):827. PubMed ID: 5278972 [No Abstract] [Full Text] [Related]
51. [A CASE OF LEUKEMIA IN A LACTATING FEMALE: EFFECT OF TREATMENT WITH BUSULFAN ON THE INFANT]. BOUNAMEAUX Y; DURENNE JM Ann Soc Belges Med Trop Parasitol Mycol; 1964; 44():381-3. PubMed ID: 14259241 [No Abstract] [Full Text] [Related]
55. Jaundice after treatment of leukemia with busulphan. Underwood JC; Shahani RT; Blackburn EK Br Med J; 1971 Mar; 1(5748):556-7. PubMed ID: 5280623 [No Abstract] [Full Text] [Related]
56. [Preliminary results of myelobromol treatment of chronic granulocytic leukemia]. Urasiński I; Mysik M Wiad Lek; 1971 Jul; 24(3):271-4. PubMed ID: 5279032 [No Abstract] [Full Text] [Related]
57. [Kinetic constants of leukocyte reduction in the course of treatment of chronic myeloleukosis with different doses of myelosan]. Levitin EI; Kukharenko IuA; Evsenko LS; Emanuel' NM Izv Akad Nauk SSSR Biol; 1968; 5():739-43. PubMed ID: 5262634 [No Abstract] [Full Text] [Related]